Susanna Naggie, MD

Closed portfolio with a later-stage archive tilt

According to ClinicalTrials.gov-derived indexes, Susanna Naggie, MD sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).

8 total trials none currently recruiting 8 completed later-stage tilt upper quartile by trial count

Susanna Naggie, MD: 8 sponsored US clinical trials, none currently recruiting.

Susanna Naggie, MD sponsors 8 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 8 completed. 8 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is COVID-19, with 2 trials.

Upper-quartile sponsor footprint

Susanna Naggie, MD sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

8 total, page 1 of 1

COMPLETED Phase 3

ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)

NCT06042855
COMPLETED Phase 3

ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast)

NCT05894577
COMPLETED Phase 3

ACTIV-6: COVID-19 Study of Repurposed Medications - Arm E (Fluvoxamine 100)

NCT05894564
COMPLETED Phase 3

ACTIV-6: COVID-19 Study of Repurposed Medications - Arm D (Ivermectin 600)

NCT05894538
COMPLETED Phase 3

ACTIV-6: COVID-19 Study of Repurposed Medications - Arm C (Fluticasone)

NCT05736874
COMPLETED Phase 3

ACTIV-6: COVID-19 Study of Repurposed Medications - Arm A (Ivermectin 400)

NCT05736861
COMPLETED Phase 3

ACTIV-6: COVID-19 Study of Repurposed Medications

NCT04885530
COMPLETED Phase 3

ACTIV-6: COVID-19 Study of Repurposed Medications - Arm B (Fluvoxamine)

NCT05890586

Phase Distribution

PhaseTrial count
Phase 3 8

Therapeutic Areas

COVID-19 2

How the Susanna Naggie, MD archive is shaped

8 indexed studies, none listed as recruiting (0% open); 8 completed (100%).

Phase mix: 8 late (III/IV) vs 0 early (I/II) (later-stage heavy).

Top condition: COVID-19 (2 trials), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Susanna Naggie, MD: archived-pipeline peers nationwide

Peers matched on 8 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Susanna Naggie, MD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40% Total trials Recruiting share Susanna Naggie, MDAB ScienceAbbott Point of CareAbeona TherapeuticsAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)10xBio22nd Century Group23andMe3-C Institute for Social Development
Susanna Naggie, MD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Susanna Naggie, MD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 8 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Susanna Naggie, MD page

8 registered trials is a research-attention snapshot, not an endorsement of Susanna Naggie, MD or any single study.

  • None of Susanna Naggie, MD's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • COVID-19 is the condition Susanna Naggie, MD studies most, compare against other sponsors active in the same condition before evaluating a specific study. See COVID-19 trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Susanna Naggie, MD pipeline card: 8 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.